224 related articles for article (PubMed ID: 31639755)
1. Common Hormone Therapies Used to Care for Transgender Patients Influence Laboratory Results.
Humble RM; Imborek KL; Nisly N; Greene DN; Krasowski MD
J Appl Lab Med; 2019 Mar; 3(5):799-814. PubMed ID: 31639755
[TBL] [Abstract][Full Text] [Related]
2. Hematology reference intervals for transgender adults on stable hormone therapy.
Greene DN; McPherson GW; Rongitsch J; Imborek KL; Schmidt RL; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
Clin Chim Acta; 2019 May; 492():84-90. PubMed ID: 30771301
[TBL] [Abstract][Full Text] [Related]
3. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
4. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
Humble RM; Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2022 Sep; 7(5):1131-1144. PubMed ID: 35584132
[TBL] [Abstract][Full Text] [Related]
5. Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals.
Cheung AS; Lim HY; Cook T; Zwickl S; Ginger A; Chiang C; Zajac JD
J Clin Endocrinol Metab; 2021 Mar; 106(3):893-901. PubMed ID: 32810277
[TBL] [Abstract][Full Text] [Related]
6. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
8. When Gender Identity Doesn't Equal Sex Recorded at Birth: The Role of the Laboratory in Providing Effective Healthcare to the Transgender Community.
Goldstein Z; Corneil TA; Greene DN
Clin Chem; 2017 Aug; 63(8):1342-1352. PubMed ID: 28679645
[TBL] [Abstract][Full Text] [Related]
9. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
10. Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.
de Haan G; Santos GM; Arayasirikul S; Raymond HF
LGBT Health; 2015 Dec; 2(4):313-23. PubMed ID: 26788772
[TBL] [Abstract][Full Text] [Related]
11. Reproductive Endocrinology Reference Intervals for Transgender Men on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston-McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):41-50. PubMed ID: 33241847
[TBL] [Abstract][Full Text] [Related]
12. Gender affirming medical care of transgender youth.
Salas-Humara C; Sequeira GM; Rossi W; Dhar CP
Curr Probl Pediatr Adolesc Health Care; 2019 Sep; 49(9):100683. PubMed ID: 31735692
[TBL] [Abstract][Full Text] [Related]
13. Implications for medication dosing for transgender patients: A review of the literature and recommendations for pharmacists.
Webb AJ; McManus D; Rouse GE; Vonderheyde R; Topal JE
Am J Health Syst Pharm; 2020 Mar; 77(6):427-433. PubMed ID: 32012216
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hormone Therapy on Laboratory Values in Transgender Patients.
SoRelle JA; Jiao R; Gao E; Veazey J; Frame I; Quinn AM; Day P; Pagels P; Gimpel N; Patel K
Clin Chem; 2019 Jan; 65(1):170-179. PubMed ID: 30518663
[TBL] [Abstract][Full Text] [Related]
15. Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals.
Solotke MT; Liu P; Dhruva SS; Gulanski B; Shah ND; Ross JS
LGBT Health; 2020 Apr; 7(3):137-145. PubMed ID: 32267818
[No Abstract] [Full Text] [Related]
16. Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people.
Quinn VP; Nash R; Hunkeler E; Contreras R; Cromwell L; Becerra-Culqui TA; Getahun D; Giammattei S; Lash TL; Millman A; Robinson B; Roblin D; Silverberg MJ; Slovis J; Tangpricha V; Tolsma D; Valentine C; Ward K; Winter S; Goodman M
BMJ Open; 2017 Dec; 7(12):e018121. PubMed ID: 29284718
[TBL] [Abstract][Full Text] [Related]
17. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
18. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
19. Clinically Relevant Laboratory Monitoring of Gender-Affirming Hormone Therapy in Transgender People-Experiences from a Teaching Hospital in the Netherlands.
Pouw N; van der Linden J; Teuben S; Kos S
J Appl Lab Med; 2024 May; 9(3):440-455. PubMed ID: 38452266
[TBL] [Abstract][Full Text] [Related]
20. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
